Generate Biomedicines, Inc.
GENB
$15.64
$0.614.06%
NASDAQ
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -12.60% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -12.60% | ||||
| Cost of Revenue | 11.27% | ||||
| Gross Profit | -14.68% | ||||
| SG&A Expenses | 0.55% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 9.24% | ||||
| Operating Income | -11.70% | ||||
| Income Before Tax | -8.94% | ||||
| Income Tax Expenses | 89.29% | ||||
| Earnings from Continuing Operations | -8.98% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -9.45% | ||||
| EBIT | -11.70% | ||||
| EBITDA | -5.00% | ||||
| EPS Basic | 50.84% | ||||
| Normalized Basic EPS | 44.51% | ||||
| EPS Diluted | 50.84% | ||||
| Normalized Diluted EPS | 44.51% | ||||
| Average Basic Shares Outstanding | 97.68% | ||||
| Average Diluted Shares Outstanding | 97.68% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||